comparemela.com

Latest Breaking News On - Synthetic cannabinoid agonist - Page 1 : comparemela.com

LADENBURG THALM/SH SH Reiterates Buy Rating for Artelo Biosciences (NASDAQ:ARTL)

Artelo Biosciences (NASDAQ:ARTL – Get Rating)‘s stock had its “buy” rating restated by analysts at LADENBURG THALM/SH SH in a note issued to investors on Monday, Benzinga reports. They currently have a $60.00 target price on the stock. Separately, HC Wainwright reaffirmed a “buy” rating and issued a $55.00 price target on shares of Artelo […]

Artelo Biosciences, Inc (NASDAQ:ARTL) Short Interest Down 30 3% in March

Artelo Biosciences, Inc. (NASDAQ:ARTL – Get Rating) was the target of a significant drop in short interest in March. As of March 15th, there was short interest totalling 38,900 shares, a drop of 30.3% from the February 28th total of 55,800 shares. Approximately 1.4% of the shares of the stock are sold short. Based on […]

Analysts Anticipate Artelo Biosciences, Inc (NASDAQ:ARTL) Will Post Earnings of -$0 06 Per Share

Wall Street analysts forecast that Artelo Biosciences, Inc. (NASDAQ:ARTL – Get Rating) will report earnings per share of ($0.06) for the current quarter, according to Zacks. Zero analysts have made estimates for Artelo Biosciences’ earnings. Artelo Biosciences reported earnings per share of ($0.11) in the same quarter last year, which suggests a positive year over […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.